483 Response Grifols Biologicals May 2000

Jacqueline Diaz Albert FDA, Mariza Jafary FDA, Kham Phommachanh FDA$119.00 - Available Now

FDA investigators audited the Grifols Biologicals - Los Angeles, CA, United States facility and issued inspectional observation (via FDA 483) on 04 May 2000.

Product details

  • Category:
  • Inspection end: 04 May 2000
  • Location: Los Angeles, United States
  • FEI: 2080769
Add To Cart